“Head and Neck Atopic Dermatitis: Therapeutic Response After Switching to Upadacitinib in Moderate-to-Severe Atopic Dermatitis Patients Who Had Inadequate Response to Dupilumab” (2026) SKIN The Journal of Cutaneous Medicine, 10(2), p. s740. doi:10.25251/ztj3rn69.